Sugarbaker P H
Ann Surg. 1976 Dec;184(6):752-7. doi: 10.1097/00000658-197612000-00016.
Four of 40 patients with resectable colon or rectal cancer had tumors causing acute large bowel obstruction with colonic dilatation; all 4 patients had preoperative CEA titers above 10 ng/ml with a mean of 28 ng/ml. Thirty-six cancer patients without acute colon obstruction had a mean CEA titer of 4.5 ng/ml; only 6 of 36 patients had circulating CEA titers 10 ng/ml or greater. This suggested that pre-treatment CEA titers in patients with obstructing cancer are unusually high. Multiple CEA assays were performed on two of the 4 patients with colonic obstruction before and after bowel decompressive procedures and prior to their definitive treatment. Relief of obstruction alone produces marked reduction in circulating CEA; this suggested that not only the extent of disease but also the pathophysiological changes associated with obstruction influenced circulating CEA levels.
40例可切除结肠癌或直肠癌患者中有4例肿瘤导致急性大肠梗阻伴结肠扩张;所有4例患者术前癌胚抗原(CEA)滴度均高于10 ng/ml,平均为28 ng/ml。36例无急性结肠梗阻的癌症患者CEA滴度平均为4.5 ng/ml;36例患者中只有6例循环CEA滴度为10 ng/ml或更高。这表明梗阻性癌症患者的治疗前CEA滴度异常高。对4例结肠梗阻患者中的2例在肠道减压手术前后及确定性治疗前进行了多次CEA检测。单纯梗阻缓解可使循环CEA显著降低;这表明不仅疾病范围,而且与梗阻相关的病理生理变化也会影响循环CEA水平。